In the regional breakdown by per capita spending volumes for January–August 2026, Moscow Oblast leads, where the indicator exceeded RUB 12,400 per person, demonstrating annual growth of 12.9%.

Pharmaceutical enterprises localized in Russia demonstrate steady expansion of the physical volume of finished medicinal product (FMP) output, accompanied by stable growth in the industry's total monetary value.

This year, the situation with sales of non-drug products in Russian pharmaceutical retail has somewhat stabilized.

Pharmaceutical distributors ranking by market share of direct drug supplies in Q1–Q2 2026.

In January–July 2026, the Russian pharmaceutical industry maintained an upward trend, with growth, as before, almost entirely driven by prescription drugs.

Pharmacy chains and associations ranking by share of sales through own online services in Q1–Q2 2026.

In the first half of 2026, a pronounced stagnation of the assortment matrix was recorded on the domestic pharmaceutical market.

In the first half of 2026, the Russian pharmaceutical industry demonstrated confident positive dynamics in both value and physical terms.